Haemonetics Corporation
HAE
$81.35
$0.600.74%
NYSE
| 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/28/2024 | 09/28/2024 | |
|---|---|---|---|---|---|
| Net Income | 168.19M | 163.34M | 167.68M | 130.07M | 123.81M |
| Total Depreciation and Amortization | 107.55M | 108.51M | 108.89M | 106.42M | 100.92M |
| Total Amortization of Deferred Charges | 6.70M | 6.70M | 6.70M | 8.60M | 8.60M |
| Total Other Non-Cash Items | 25.54M | 20.39M | -5.65M | 8.45M | 12.42M |
| Change in Net Operating Assets | -18.94M | -72.39M | -95.89M | -124.29M | -160.81M |
| Cash from Operations | 289.04M | 226.54M | 181.73M | 129.25M | 84.94M |
| Capital Expenditure | -55.35M | -37.38M | -39.28M | -30.32M | -25.65M |
| Sale of Property, Plant, and Equipment | 3.12M | 3.19M | 23.25M | 21.35M | 21.44M |
| Cash Acquisitions | 0.00 | -1.76M | -150.91M | -150.91M | -394.76M |
| Divestitures | 43.29M | 43.29M | 43.29M | 1.50M | 1.50M |
| Other Investing Activities | -53.86M | -63.05M | -38.26M | -34.62M | -47.09M |
| Cash from Investing | -62.80M | -55.70M | -161.90M | -192.99M | -444.56M |
| Total Debt Issued | 0.00 | 0.00 | 950.00M | 950.00M | 1.06B |
| Total Debt Repaid | -6.25M | 83.51M | -502.69M | -564.63M | -566.56M |
| Issuance of Common Stock | 7.68M | 7.87M | 8.33M | 8.30M | 7.68M |
| Repurchase of Common Stock | -230.24M | -230.27M | -235.24M | -85.24M | -84.84M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -251.00K | -88.42M | -111.58M | -111.67M | -111.46M |
| Cash from Financing | -229.06M | -227.32M | 108.82M | 196.77M | 304.82M |
| Foreign Exchange rate Adjustments | -33.00K | 4.94M | -685.00K | -6.16M | 3.08M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.86M | -51.53M | 127.96M | 126.87M | -51.72M |